Cary J. Claiborne - 07 Dec 2021 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Operating Officer, Director
Signature
/s/ Cary J. Claiborne
Issuer symbol
ADIL
Transactions as of
07 Dec 2021
Net transactions value
$0
Form type
4
Filing time
08 Dec 2021, 20:23:51 UTC
Previous filing
03 Nov 2021
Next filing
25 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock options Award $0 +130,000 $0.000000 130,000 07 Dec 2021 Common stock 130,000 $2.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months.